HealOr is a developer of new treatments for acute and chronic wounds such as diabetic foot ulcer (DFU), psoriasis and others.
Most recently, Sabolinski has worked as the chief medical officer of the company.
Sabolinski said he look forward to working closely with the company’s supportive Board of Directors.
"Our main goal is to achieve FDA approval for HO/03/03, our flagship product for the treatment of diabetic foot ulcers, which is currently being studied in a Phase II/III clinical trial in the US and India," Sabolinski said.